Zhongtai Securities(SH:600918) Xin Lang Cai Jing·2025-09-19 06:32Core Viewpoint - On September 19, 2023, Shenzhen Xinlitai Pharmaceutical Co., Ltd. experienced a stock decline of 5.14%, with a trading price of 51.70 yuan per share and a total market capitalization of 57.636 billion yuan [1] Company Overview - Shenzhen Xinlitai Pharmaceutical Co., Ltd. was established on November 3, 1998, and listed on September 10, 2009. The company is located in the Futian District of Shenzhen, Guangdong Province [1] - The main business activities include research, production, and sales of pharmaceuticals and medical devices. The revenue composition is as follows: formulations 81.69%, medical devices 8.54%, raw materials 7.17%, and others 2.59% [1] Fund Holdings - According to data from fund holdings, one fund under Zhongtai Securities Asset Management has a significant position in Xinlitai. The Zhongtai Xingrui Prosperity Growth Mixed A Fund (018372) reduced its holdings by 24,800 shares in the second quarter, holding a total of 70,300 shares, which represents 3.07% of the fund's net value, making it the fourth-largest holding [2] - The fund has a current scale of 41.0179 million yuan and has achieved a year-to-date return of 36.03%, ranking 2102 out of 8172 in its category. Over the past year, the return is 50.34%, ranking 3198 out of 7980 [2] Fund Manager Information - The fund manager of Zhongtai Xingrui Prosperity Growth Mixed A Fund is Gao Lanjun, who has been in the position for 6 years and 93 days. The total asset scale of the fund is 108 million yuan, with the best return during the tenure being 126.62% and the worst return being 14.33% [3]